Integrins in mammary gland development and differentiation of mammary epithelium

Journal of Mammary Gland Biology and Neoplasia

Volumn 8, Issue 4, 2003, Pages 383-394

  Taddei, Ilaria ^a   Faraldo, Marisa M ^a   Teulière, Jérôme ^a   Deugnier, Marie Ange ^a   Thiery, Jean Paul ^a   Glukhova, Marina A ^a  

^a INSTITUT CURIE   (France)

Author keywords

Differentiation; Integrins; Mammary epithelium; Morphogenesis; Tumor progression

Indexed keywords

ALPHA1 INTEGRIN; ALPHA2 INTEGRIN; ALPHA3 INTEGRIN; ALPHA5 INTEGRIN; ALPHA6 INTEGRIN; BETA1 INTEGRIN; BETA4 INTEGRIN; CD51 ANTIGEN; CELL RECEPTOR; INTEGRIN; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BAX; PROTEIN KINASE B; PROTEIN SHC; PROTEIN TYROSINE KINASE; RAS PROTEIN; REGULATOR PROTEIN; STAT5 PROTEIN; VERY LATE ACTIVATION ANTIGEN 3; VERY LATE ACTIVATION ANTIGEN 5;

BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; CELL ANCHORAGE; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; HUMAN; MORPHOGENESIS; NONHUMAN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

ANIMALS; BREAST NEOPLASMS; CELL DIFFERENTIATION; EPITHELIUM; HUMANS; INTEGRINS; MAMMARY GLANDS, ANIMAL; MORPHOGENESIS;

EID: 4344560651     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/B:JOMG.0000017426.74915.b9     Document Type: Review

References (78)

1. R. O. Hynes (2002). Integrins: Bidirectional, allosteric signaling machines. Cell 110:673-687.
2. F. G. Giancotti and E. Ruoslahti (1999). Integrin signaling. Science 285:1028-1032.
3. F. G. Giancotti and G. Tarone (2003). Positional control of cell fate through joint integrin/receptor protein kinase signaling. Annu. Rev. Cell Dev. Biol. 19:173-206.
4. C. K. Miranti and J. S. Brugge (2002). Sensing the environment: A historical perspective on integrin signal transduction. Nat. Cell Biol. 4:E83-E90.
5. G. M. Edwards, F. H. Wilford, X. Liu, L. Hennighausen, J. Djiane, and C. H. Streuli (1998). Regulation of mammary differentiation by extracellular matrix involves protein-tyrosine phosphatases. J. Biol. Chem. 273:9495-9500.
6. C. H. Streuli, G. M. Edwards, M. Delcommenne, C. B. Whitelaw, T. G. Burdon, C. Schindler, et al. (1995). Stat5 as a target for regulation by extracellular matrix. J. Biol. Chem. 270:21639-21644.
7. S. Z. Haslam and T. L. Woodward (2001). Reciprocal regulation of extracellular matrix proteins and ovarian steroid activity in the mammary gland. Breast Cancer Res. 3:365-372.
8. L. Shaw (1999). Integrin function in breast carcinoma progression. J. Mammary Gland Bio. Neoplasia 4:367-376.
9. T. L. Woodward, A. S. Mienaltowski, R. R. Modi, J. M. Bennet, and S. Z. Haslam (2001). Fibronectin and the alpha(5)beta(1) integrin are under developmental and ovarian steroid regulation in the normal mouse mammary gland. Endocrinology 142:3214-3222.
10. M. Delcommenne and C. H. Streuli (1995). Control of integrin expression by extracellular matrix. J. Biol. Chem. 270:26794-26801.
11. R. Y. Huang and M. M. Ip (2001). Differential expression of integrin mRNAs and proteins during normal rat mammary gland development and in carcinogenesis. Cell Tissue Res. 303:69-80.
12. P. J. Keely, J. E. Wu, and S. A. Santoro (1995). The spatial and temporal expression of the alpha 2 beta 1 integrin and its ligands, collagen I, collagen IV, and laminin, suggest important roles in mouse mammary morphogenesis. Differentiation 59:1-13.
13. J. M. Prince, T. C. Klinowska, E. Marshman, E. T. Lowe, U. Mayer, J. Miner, et al. (2002). Cell matrix interactions during development and apoptosis of the mouse mammary gland in vivo. Dev. Dyn. 223:497-516.
14. T. Iype, K. Jayasree, and P. R. Sudhakaran (2001). Modulation of alpha2beta1 integrin changes during mammary gland development by beta-oestradiol. Biochim. Biophys. Acta 1499:232-241.
15. C. Forster, S. Makela, A. Warri, S. Kietz, D. Becker, K. Hultenby, et al. (2002). Involvement of estrogen receptor beta in terminal differentiation of mammary gland epithelium. Proc. Natl. Acad. Sci. U.S.A. 99:15578-15583.
16. V. Novaro, C. D. Roskelley, and M. J. Bissell (2003). Collagen-IV and laminin-1 regulate estrogen receptor alpha expression and function in mouse mammary epithelial cells. J. Cell Sci. 116:2975-2986.
17. M. A. Deugnier, E. P. Moiseyeva, J. P. Thiery, and M. A. Glukhova (1995). Myoepithelial cell differentiation in the developing mammary gland: progressive acquisition of smooth muscle phenotype. Dev. Dyn. 204:107-117.
18. R. Suzuki, A. J. Atherton, M. J. O'Hare, A. Entwistle, S. R. Lakhani, and C. Clarke (2000). Proliferation and differentiation in the human breast during pregnancy. Differentiation 66:106-115.
19. R. N. Suzuki, A. Entwistle, A. J. Atherton, C. Clarke, S. R. Lakhani, and M. J. O'Hare (2002). The expression patterns of integrin subunits on human breast tissues obtained during pregnancy. Cell Biol. Int. 26:593-598.
20. M. A. Schwartz and R. K. Assoian (2001). Integrins and cell proliferation: regulation of cyclin -dependent kinases via cytoplasmic signaling pathways. J. Cell Sci. 114:2553-2560.
21. N. Boudreau, C. J. Sympson, Z. Werb, and M. J. Bissell (1995). Supression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891-893.
22. A. P. Gilmore, A. D. Metcalfe, L. H. Romer, and C. H. Streuli (2000). Integrin-mediated survival signals regulate the apoptotic function of Bax through its conformation and subcellular localization. J. Cell Biol. 149:431-446.
23. P. Wang, A. J. Valentijn, A. P. Gilmore, and C. H. Streuli (2003). Early events in the anoikis program occur in the absence of caspase activation. J. Biol. Chem. 278:19917-19925.
24. M. J. Reginato, K. R. Mills, J. K. Paulus, D. K. Linch, D. C. Sgroi, J. Debnath, et al. (2003). Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat. Cell Biol. 6:6.
25. S. R. Datta, A. Brunet, and M. E. Greenberg (1999). Cellular survival: A play in three Akts. Genes Dev. 13:2905-2927.
26. N. Farrelly, Y. J. Lee, J. Oliver, C. Dive, and C. H. Streuli (1999). Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J. Cell. Biol. 144:1337-1348.
27. Y. J. Lee and C. H. Streuli (1999). Extracellular matrix selectively modulates the response of mammary epithelial cells to different soluble signaling ligands. J. Biol. Chem. 274:22401-22408.
28. V. M. Weaver, O. W. Petersen, F. Wang, C. A. Larabell, P. Briand, C. Damsky, et al. (1997). Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J. Cell Biol. 137:231-245.
29. V. M. Weaver, S. Lelievre, J. N. Lakins, C. A. Larabell, P. Briand, C. Damsky, et al. (2002). Beta4 integrin-dependent formation of polarized three-dimensional architecture confers resistance to apoptosis in normal and malignant mammary epithelium. Cancer Cell 2:205-216.
30. F. Wang, V. M. Weaver, O. W. Petersen, C. A. Larabell, S. Dedhar, P. Briand, et al. (1998). Reciprocal interactions between beta1-integrin and epidermal growth factor receptor in three-dimensional basement membrane breast cultures: A different perspective in epithelial biology. Proc. Natl. Acad. Sci. U.S.A. 95:14821-14826.
31. F. Wang, R. K. Hansen, D. Radisky, T. Yoneda, M. H. Barcellos-Hoff, O. W. Petersen, et al. (2002). Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J. Natl. Cancer Inst. 94:1494-1503.
32. M. M. Faraldo, M. A. Deugnier, M. Lukashev, J. P. Thiery, and M. A. Glukhova (1998). Perturbation of beta1-integrin function alters the development of murine mammary gland. Embo. J. 17:2139-2147.
33. M. M. Faraldo, M. A. Deugnier, J. P. Thiery, and M. A. Glukhova (2001). Growth defects induced by perturbation of [beta)1-integrin function in the mammary gland epithelium result from a lack of MAPK activation via the She and Akt pathways. EMBO Rep. 2:431-437.
34. V. L. Seewaldt, K. Mrozek, R. Sigle, E. C. Dietze, K. Heine, D. M. Hockenbery, et al. (2001). Suppression of p53 function in normal human mammary epithelial cells increases sensitivity to extracellular matrix-induced apoptosis. J. Cell Biol. 155:471-486.
35. R. E. Bachelder, A. Marchetti, R. Falcioni, S. Soddu, and A. M. Mercurio (1999). Activation of p53 function in carcinoma cells by the alpha6beta4 integrin. J. Biol. Chem. 274:20733-20737.
36. L. Hennighausen and G. W. Robinson (2001). Signaling pathways in mammary gland development. Dev. Cell 1:467-475.
37. C. H. Streuli, C. Schmidhauser, N. Bailey, P. Yurchenco, A. P. Skubitz, C. Roskelley, et al. (1995). Laminin mediates tissue-specific gene expression in mammary epithelia. J. Cell Biol. 129:591-603.
38. J. Muschler, A. Lochter, C. D. Roskelley, P. Yurchenco, M. J. Bissell (1999). Division of labor among the alpha6beta4 integrin, beta1 integrins, and an E3 laminin receptor to signal morphogenesis and beta-casein expression in mammary epithelial cells. Mol. Biol. Cell 10:2817-2828.
39. M. M. Faraldo, M. A. Deugnier, S. Tlouzeau, J. P. Thiery, and M. A. Glukhova (2002). Perturbation of beta1-integrin function in involuting mammary gland results in premature dedifferentiation of secretory epithelial cells. Mol. Biol. Cell 13:3521-3531.
40. S. Geymayer and W. Doppler (2000). Activation of NF-kappaB p50/p65 is regulated in the developing mammary gland and inhibits STAT5-mediated beta-casein gene expression. Faseb J. 14:1159-1170.
41. H. Gardner, J. Kreidberg, V. Koteliansky, and R. Jaenisch (1996). Deletion of integrin alpha 1 by homologous recombination permits normal murine development but gives rise to a specific deficit in cell adhesion. Dev. Biol. 175:301-313.
42. J. Chen, T. G. Diacovo, D. G. Grenache, S. A. Santoro, and M. M. Zutter (2002). The alpha(2) integrin subunit-deficient mouse: A multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am. J. Pathol. 161:337-344.
43. T. C. Klinowska, C. M. Alexander, E. Georges-Labouesse, R. Van der Neut, J. A. Kreidberg, C. J. Jones, et al. (2001). Epithelial development and differentiation in the mammary gland is not dependent on alpha 3 or alpha 6 integrin subunits. Dev. Biol. 233:449-467.
44. M. E. El-Sabban, A. J. Sfeir, M. H. Daher, N. Y. Kalaany, R. A. Bassam, and R. S. Talhouk (2003). ECM-induced gap junctional communication enhances mammary epithelial cell differentiation. J. Cell Sci. 116:3531-3541.
45. M. A. Deugnier, M. M. Faraldo, P. Rousselle, J. P. Thiery, and M. A. Glukhova (1999). Cell-extracellular matrix interactions and EGF are important regulators of the basal mammary epithelial cell phenotype. J. Cell Sci. 112:1035-1044.
46. B. S. Wiseman and Z. Werb (2002). Stromal effects on mammary gland development and breast cancer. Science 296:1046-1049.
47. F. Berdichevsky, D. Alford, B. D'Souza, and J. Taylor-Papadimitriou (1994). Branching morphogenesis of human mammary epithelial cells in collagen gels. J. Cell Sci. 107:3557-3566.
48. S. Stahl, S. Weitzman, and J. C. Jones (1997). The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis. J Cell Sci. 110:55-63.
49. T. Gudjonsson, L. Ronnov-Jessen, R. Villadsen, F. Rank, M. J. Bissell, and O. W. Petersen (2002). Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci. 115:39-50.
50. N. Koshikawa, G. Giannelli, V Cirulli, K. Miyazaki, and V. Quaranta (2000). Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J. Cell Biol. 148:615-624.
51. M. A. Deugnier, M. M. Faraldo, B. Janji, P. Rousselle, J. P. Thiery, and M. A. Glukhova (2002). EGF controls Me in vivo developmental potential of a mammary epithelial cell line possessing progenitor properties. J. Cell Biol. 159:453-463.
52. T. C. Klinowska, J. V. Soriano, G. M. Edwards, J. M. Oliver, A. J. Valentijn, and R. Montesano (1999). Laminin and beta1 integrins are crucial for normal mammary gland development in the mouse. Dev. Biol. 215:13-32.
53. T. Sakai, M. Larsen, and K. M. Yamada (2003). Fibronectin requirement in branching morphogenesis. Nature 423:876-881.
54. B. S. Wiseman, M. D. Sternlicht, L. R. Lund, C. M. Alexander, J. Mott, M. J. Bissell, et al. (2003). Site-specific inductive and inhibitory activities of MMP-2 and MMP-3 orchestrate mammary gland branching morphogenesis. J. Cell Biol. 162:1123-1133.
55. V. Gouon-Evans, M. E. Rothenberg, and J. W. Pollard (2000). Postnatal mammary gland development requires macrophages and eosinophils. Development 127:2269-2282.
56. K. Friedrichs, P. Ruiz, F. Franke, I. Gille, H. J. Terpe, and B. A. Imhof (1995). High expression level of alpha 6 integrin in human breast carcinoma is correlated with reduced survival. Cancer Res. 55:901-906.
57. U. M. Wewer, L. M. Shaw, R. Albrechtsen, and A. M. Mercurio (1997). The integrin alpha 6 beta 1 promotes the survival of metastatic human breast carcinoma cells in mice. Am. J. Pathol. 151:1191-1198.
58. A. M. Mercurio, R. E. Bachelder, J. Chung, K. L. O'Connor, I. Rabinovitz, and L. M. Shaw (2001). Integrin laminin receptors and breast carcinoma progression. J. Mammary Gland Biol. Neoplasia 6:299-309.
59. K. L. O'Connor and A. M. Mercurio (2001). Protein kinase A regulates Rac and is required for the growth factor-stimulated migration of carcinoma cells. J. Biol. Chem. 276:47895-47900.
60. I. Rabinovitz, I. K. Gipson, and A. M. Mercurio (2001). Traction forces mediated by alpha6beta4 integrin: Implications for basement membrane organization and tumor invasion. Mol. Biol. Cell 12:4030-4043.
61. M. J. Arboleda, J. F. Lyons, F. F. Kabbinavar, M. R. Bray, B. E. Snow, and R. Ayala (2003). Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res. 63:196-206.
62. M. Morini, M. Mottolese, N. Ferrari, F. Ghiorzo, S. Buglioni, and R. Mortarini (2000). The alpha 3 beta 1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int. J. Cancer 87:336-342.
63. T. Sugiura and F. Berditchevski (1999). Function of alpha3beta1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J. Cell Biol. 146:1375-1389.
64. A. Lochter, M. Navre, Z. Werb, and M. J. Bissell (1999). Alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression. Mol. Biol. Cell 10:271-282.
65. E. I. Deryugina, B. Ratnikov, E. Monosov, T. I. Postnova, R. DiScipio, J. W. Smith, et al. (2001). MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp. Cell Res. 263:209-223.
66. E. I. Deryugina, B. I. Ratnikov, T. I. Postnova, D. V. Rozanov, and A. Y. Strongin (2002). Processing of integrin alpha(v) subunit by membrane type 1 matrix metalloproteinase stimulates migration of breast carcinoma cells on vitronectin and enhances tyrosine phosphorylation of focal adhesion kinase. J. Biol. Chem. 277:9749-9756.
67. B. I. Ratnikov, D. V. Rozanov, T. I. Postnova, P. G. Baciu, H. Zhang, R. G. DiScipio, et al. (2002). An alternative processing of integrin alpha(v) subunit in tumor cells by membrane type-1 matrix metalloproteinase. J. Biol. Chem. 277:7377-7385.
68. B. Felding-Habermann, T. E. O'Toole, J. W. Smith, E. Fransvea, Z. M. Ruggeri, M. H. Ginsberg, et al. (2001). Integrin activation controls metastasis in human breast cancer. Proc. Natl. Acad. Sci. USA. 98:1853-1858.
69. M. Rolli, E. Fransvea, J. Pilch, A. Saven, and B. Felding-Habermann (2003). Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells. Proc. Natl. Acad. Sci. U.S.A. 100:9482-9487.
70. I. Pecheur, O. Peyruchaud, C. M. Serre, J. Guglielmi, C. Voland, F. Bourre, et al. (2002). Integrin alpha(v)beta3 expression confers on tumor cells a greater propensity to metastasize to bone. FASEB J. 16:1266-1368.
71. J. P. Thiery (2002). Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer 2:442-454.
72. K. Kawano, S. S. Kantak, M. Murai, C. C. Yao, and R. H. Kramer (2001). Integrin alpha3beta1 engagement disrupts intercellular adhesion. Exp. Cell Res. 262:180-196.
73. G. E. Plopper, S. Z. Domanico, V. Cirulli, W. B. Mosses, and V. Quaranta (1998). Migration of breast epithelial cells on Laminin-5: Differential role of integrins in normal and transformed cell types. Breast Cancer Res. Treat. 51:57-69.
74. G. E. Plopper, J. L. Huff, W. L. Rust, M. A. Schwartz, and V. Quaranta (2000). Antibody-induced activation of beta1 integrin receptors stimulates cAMP-dependent migration of breast cells on laminin-5. Mol. Cell Biol. Res. Commun. 4:129-135.
75. Y. Wei, J. A. Eble, Z. Wang, J. A. Kreidberg, and H. A. Chapman (2001). Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1. Mol. Biol. Cell 12:2975-2986.
76. F. Zhang, C. C. Tom, M. C. Kugler, T. T. Ching, J. A. Kreidberg, Y. Wei, et al. (2003). Distinct ligand binding sites in interne α3β1regulate matrix adhesion and cell-cell contact. J. Cell Biol. 163:177-188.
77. N. A. Bhowmick, R. Zent, M. Ghiassi, M. McDonnell, and H. L. Moses (2001). Integrin beta 1 signaling is necessary for transforming growth factor-beta activation of p38MAPK and epithelial plasticity. J. Biol. Chem. 276:46707-46713.
78. D. Wang, L. Sun, E. Zborowska, J. K. Willson, J. Gong, J. Verraraghavan, et al. (1999). Control of type II transforming growth factor-beta receptor expression by integrin ligation. J. Biol. Chem. 274:12840-12847.